Sex (biological and physiological characteristics) differences are increasingly being studied to assess symptoms, risk factors and outcomes for various diseases. Now, a new pan-Canadian study led by a team from the Research ...
Feb 1, 2016
0
3
(HealthDay)—Knowledge of coronary computed tomography angiography (CCTA) results is associated with improved alignment of aspirin and statin prescribing with the presence and severity of coronary artery disease (CAD), according ...
Jan 26, 2016
0
11
New recommendations from the American College of Cardiology and American College of Radiology have established appropriate use of diagnostic imaging for patients with chest pain, one of the most common reasons for emergency ...
Jan 22, 2016
0
2
(HealthDay)—The addition of lixisenatide to usual care does not impact the rate of major cardiovascular events or other serious adverse events among patients with type 2 diabetes and a recent acute coronary syndrome, according ...
Dec 3, 2015
0
0
Patients with acute coronary syndrome who have undergone angioplasty have a reduced risk of all-cause in-hospital mortality but an increased risk of bleeding when given glycoprotein 2b/3a inhibitors (GPI) after the procedure, ...
Oct 19, 2015
0
5
Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of percutaneous coronary intervention (PCI) does not improve outcomes compared to stopping the treatment immediately after the ...
Sep 1, 2015
0
10
Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after coronary stenting "should be considered" in patients at low risk for bleeding, investigators for the OPTIDUAL trial recommend.
Sep 1, 2015
0
6
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...
Aug 31, 2015
0
10
Ezetimibe reduces cardiovascular events in patients with diabetes and a recent acute coronary syndrome, according to a subgroup analysis of the IMPROVE-IT trial presented at ESC Congress today by co-principal investigator ...
Aug 30, 2015
0
7
(HealthDay)—For patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), routine early invasive strategy (coronary arteriography and myocardial revascularization, as clinically indicated) is not associated ...
Jul 29, 2015
0
20
